Methadone Market Report
The report on the global Methadone Market is segmented by Route Of Administration (Oral [Tablets, Oral solutions], Injectable), By Therapeutic Area (Pain treatment, Detoxification, Maintenance therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Rehab centers, Drug Stores) and Region.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global methadone market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
The report on the global Methadone Market is segmented by Route Of Administration (Oral [Tablets, Oral solutions], Injectable), By Therapeutic Area (Pain treatment, Detoxification, Maintenance therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Rehab centers, Drug Stores) and Region...
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The Global Methadone Market is projected to grow from USD xx million in 2020 to USD xx million by 2026 at a CAGR of over xx % during the forecast period.
Figure: Global Methadone Market Size, 2020-2026 (USD Million)
Wish to get a free sample report? Click here.
Pain is one of the most widely recognized ailments and about 85% of individuals are accounted to suffer from pain worldwide at some point in their life. Methadone is a synthetic narcotic analgesic, which is a part of a category known as opioids. This opioid drug has pharmacologic actions qualitatively similar to that of morphine. It is mainly used as a pain reliever and as a part of maintenance therapy and drug addiction detoxification.
Key players operating in the global methadone market are-
The growing prevalence of pain associated with post-surgical and therapeutic treatment of cancer and other chronic diseases is expected to be the prime factor driving the need for methadone.
By route of administration, the global methadone market has been bifurcated into oral and injectable.
By region, the North American market garnered the largest market share in 2020 and is likely to register a healthy CAGR during the review period.
The outbreak of the COVID-19 virus has been challenging to the healthcare sector. Due to stringent lockdown measures and restricted movement on the streets, there has been a surge in drug overdosage in most parts of the world. Drug overdose deaths have substantially increased.
The US states are reporting a surge in drug fatalities in 2020 as the coronavirus pandemic has created new obstacles resulting in high opioid usage, risk, and abuse of relapse for those in recovery.
The people who are battling addiction, social distancing, and quarantine have led to disruption in treatment and recovery services as well as poor access to mental health services and peer support, thus affecting the methadone market growth.
Want to know the full scope of the report? Register Here
Here is the list of the group of customers that the Methadone market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
Eli Lilly and Company (The U.S), Sanofi (France), Roxane Laboratories (The U.S), Mallinckrodt (UK), Siegfried AG (Switzerland), Johnson Matthey (UK), Tianjin Central Pharma (China), Macfarlan Smith (UK) and Vistapharm (The U.S) are among the key players in methadone market.
North America garnered the largest share of methadone market in 2020.
The oral segment witnessed the largest share in the methadone market in 2020.
The growing prevalence of pain associated with post-surgical and therapeutic treatment of cancer and other chronic diseases is the prime factor driving the growth of methadone market.
Methadone companies, Methadone vendors, Opioid organizations, Drug addiction organizations, Hospitals are the target audience in the methadone market.